Endocrine / Hormonal
Pasireotide
Pasireotide is a multi-receptor targeted somatostatin analog with a broad binding profile across somatostatin receptor subtypes.
Evidence: 0 articles
Goals: 0
Mechanism of Action
Pasireotide functions as a somatostatin receptor agonist that binds with high affinity to multiple somatostatin receptor (SSTR) subtypes, specifically SSTR1, SSTR2, SSTR3, and SSTR5. By activating these receptors, it inhibits the secretion of various hormones, including growth hormone (GH), adrenocorticotropic hormone (ACTH), insulin, and glucagon, depending on the tissue-specific expression of the receptors.
Evidence Level
Review
0 studies published
Pharmacology
Molecular Weight
1047.2 Da